Amylyx Pharmaceuticals at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Amylyx Pharmaceuticals brings 3 presentations to ObesityWeek 2026 in National Harbor, and exhibits at Booth 701, Suite 1. Its program centres on post-bariatric hypoglycemia, the low blood sugar that can follow weight-loss surgery. One study uses US insurance claims data to find people with the condition, and the company also hosts a reception.

OrganizationObesityWeek 2026 Attendance
◇Bronze Sponsor
BiotechBronze Sponsor
Develops investigational therapies for endocrine and neurodegenerative conditions, including treatment for hypoglycemia after bariatric surgery.
Booth
Exhibiting at Booth 701, Suite 1
Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm
Session
Sun Nov 15
5:30pm–8:00pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Amylyx Pharmaceuticals

Tell us what you sell and we’ll find the people at Amylyx Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction